

HY-13404 · 10 mM * 1 mL in DMSO
MedChemExpress · Cat: HY-13404
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/INCB28060.html
Description
Capmatinib INC280; INCB28060 is a potent, orally active, selective, and ATP competitive c-Met kinase inhibitor IC50=0.13 nM . Capmatinib can inhibit phosphorylation of c-MET as well as c-MET pathway downstream effectors such as ERK1/2, AKT, FAK, GAB1, and STAT3/5. Capmatinib potently inhibits c-MET-dependent tumor cell proliferation and migration and effectively induces apoptosis. Antitumor activity. Capmatinib is largely metabolized by CYP3A4 and aldehyde oxidase.







